ITG (Germany) Announces Broad Collaboration With ANSTO (Australia) on Radioisotopes
Garching GmbH (ITG), a specialist in the development and production of
innovative radioisotopes, and
Technology Organisation (ANSTO) have agreed on a broad, long-term
collaboration on radioisotopes.
ANSTO has in-licensed the production technology for ITG’s carrier free
Lutetium-177 (Lu-177 n.c.a.) and will be the exclusive distribution partner
for ITG’s products in
Both partners have agreed to provide each other with a backup supply of
the radioisotope when needed as well as forming a collaboration for the
supply of Lu-177 n.c.a. to industrial partners in the life science industry.
Financial terms were not disclosed.
stated “This agreement is a significant milestone in the corporate
development of our company and serves as proof of the value of our production
technology for Lu-177 n.c.a. It sends a strong signal to those companies
developing Lutetium-177-based radiotherapies that global supply is
guaranteed. Furthermore, adding ANSTO to our existing network of world-wide
distribution partners closes an important geographical gap”.
Commercialisation said “This is a great opportunity for ANSTO and the
Lu-177 within the region and the collaboration between ANSTO and ITG will
underpin the future supply of an important radioisotope”.
About ITG: ITG Isotope Technologies Garching GmbH, a subsidiary of ITM
Isotopen Technologien Muenchen AG (http://www.itm.ag), develops, manufactures
and distributes world-wide innovative radio-isotopes for use in diagnosis and
About ANSTO: The Australian Nuclear Science and Technology Organisation
produces radioisotopes, isotopic techniques and nuclear radiation for
medicine, science, industry, commerce and agriculture as one of its core
functions. For more please visit: http://www.ansto.gov.au
Your contact partner for any enquiries:
ITG Isotope Technologies Garching GmbH, Dr.
1, 85748 Garching, Tel.: +49(89)289-13913, email@example.com
SOURCE ITG Isotope Technologies Garching GmbH